Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gribbon, P.
Right arrow Articles by Sewing, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gribbon, P.
Right arrow Articles by Sewing, A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Health Statistics
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Evaluating Real-Life High-Throughput Screening Data

Philip Gribbon

Automated Screening Technologies, Pfizer Global Research and Development, Sandwich, UK

Richard Lyons

Nonclinical Statistics, Pfizer Global Research and Development, Sandwich, UK

Philip Laflin

Data Support and Management Pfizer Global Research and Development, Sandwich, UK

Joe Bradley

Automated Screening Technologies, Pfizer Global Research and Development, Sandwich, UK

Chris Chambers

Automated Screening Technologies, Pfizer Global Research and Development, Sandwich, UK

Bruce S. Williams

Data Support and Management Pfizer Global Research and Development, Sandwich, UK

Wilma Keighley

Automated Screening Technologies, Pfizer Global Research and Development, Sandwich, UK

Andreas Sewing

Automated Screening Technologies, Pfizer Global Research and Development, Sandwich, UK

High-throughput screening (HTS) is the result of a concerted effort of chemistry, biology, information technology, and engineering. Many factors beyond the biology of the assay influence the quality and outcome of the screening process, yet data analysis and quality control are often focused on the analysis of a limited set of control wells and the calculated values derived from these wells. Taking into account the large number of variables and the amount of data generated, multiple views of the screening data are necessary to guarantee quality and validity of HTS results. This article does not aim to give an exhaustive outlook on HTS data analysis but tries to illustrate the shortfalls of a reductionist approach focused on control wells and give examples for further analysis.

Key Words: high-throughput screening • data analysis • assay development • biological screening

Journal of Biomolecular Screening, Vol. 10, No. 2, 99-107 (2005)
DOI: 10.1177/1087057104271957


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
I. Burr, T. Winchester, W. Keighley, and A. Sewing
Compound Management Beyond Efficiency
J Biomol Screen, June 1, 2009; 14(5): 485 - 491.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
I. Coma, L. Clark, E. Diez, G. Harper, J. Herranz, G. Hofmann, M. Lennon, N. Richmond, M. Valmaseda, and R. Macarron
Process Validation and Screen Reproducibility in High-Throughput Screening
J Biomol Screen, January 1, 2009; 14(1): 66 - 76.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
L. M. Mayr and P. Fuerst
The Future of High-Throughput Screening
J Biomol Screen, July 1, 2008; 13(6): 443 - 448.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
A. Visegrady, A. Boros, Z. Nemethy, B. Kiss, and G. M. Keseru
Application of the BD ACTOneTM Technology for the High-Throughput Screening of Gs-Coupled Receptor Antagonists
J Biomol Screen, December 1, 2007; 12(8): 1068 - 1073.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
P. Gribbon, C. Chambers, K. Palo, J. Kupper, J. Mueller, and A. Sewing
A Novel Method for Analyzing [Ca2+] Flux Kinetics in High-Throughput Screening
J Biomol Screen, August 1, 2006; 11(5): 511 - 518.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Inglese, D. S. Auld, A. Jadhav, R. L. Johnson, A. Simeonov, A. Yasgar, W. Zheng, and C. P. Austin
Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries
PNAS, August 1, 2006; 103(31): 11473 - 11478.
[Abstract] [Full Text] [PDF]